Inhibition of proliferation was shown to be similar in NCI-N87 gastric cancer cells and specific for HER2 over-expression, supporting potency results from the comprehensive similarity assessment and representing a cell type from an extrapolated indication. Here, ERBB2 is linked to gastric cancer.